Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriers
- 16 May 1998
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 351 (9114), 1487
- https://doi.org/10.1016/s0140-6736(98)24020-7
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- p53 mutations in BRCA1-associated familial breast cancerThe Lancet, 1997
- Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic casesThe Lancet, 1997
- Tumour biological features of BRCA1-induced breast and ovarian cancerEuropean Journal Of Cancer, 1997
- A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas.Journal of Clinical Pathology, 1995